The impact of oral Polypodium leucotomos extract on ultraviolet B response: A human clinical study
- 1 July 2017
- journal article
- research article
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 77 (1) , 33-41.e1
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- The role of antioxidants in photoprotection: A critical reviewJournal of the American Academy of Dermatology, 2012
- Decrease of ultraviolet A light–induced “common deletion” in healthy volunteers after oral Polypodium leucotomos extract supplement in a randomized clinical trialJournal of the American Academy of Dermatology, 2010
- Polypodium leucotomos Extract Decreases UV-Induced Cox-2 Expression and Inflammation, Enhances DNA Repair, and Decreases Mutagenesis in Hairless MiceThe American Journal of Pathology, 2009
- A clinical trial and molecular study of photoadaptation in vitiligoBritish Journal of Dermatology, 2009
- Treatment of vitiligo vulgaris with narrow‐band UVB and oral Polypodium leucotomos extract: a randomized double‐blind placebo‐controlled studyJournal of the European Academy of Dermatology and Venereology, 2007
- Oral Polypodium leucotomos extract decreases ultraviolet-induced damage of human skinJournal of the American Academy of Dermatology, 2004
- Barriers to Sun Safety in a Canadian Outpatient PopulationJournal of Cutaneous Medicine and Surgery, 2003
- Determination of UVA protection factors using the persistent pigment darkening (PPD) as the end pointPhotodermatology, Photoimmunology & Photomedicine, 2000
- Human Melanocytes and Keratinocytes Exposed to UVB or UVA In Vivo Show Comparable Levels of Thymine DimersJournal of Investigative Dermatology, 1998
- Inhibition of ultraviolet‐induced formation of reactive oxygen species, lipid peroxidation, erythema and skin photosensitization by Polypodium leucotomosPhotodermatology, Photoimmunology & Photomedicine, 1996